Followers | 29 |
Posts | 5328 |
Boards Moderated | 0 |
Alias Born | 11/29/2016 |
Wednesday, November 15, 2017 9:48:24 AM
- to expand its business through either the acquisition or the license of products and businesses that offer attractive growth characteristics and/or margins.
-The Company expects that its balance sheet and cash position will have been materially strengthened by the end of 2017.
-Tauriga remains committed as well to the commercial launch and of its licensed cupuacu butter lip balm product, branded as "HerMan". The Company will continue its efforts to generate revenue from this product in a complimentary manner to any potential acquisition or licensing activity.
-CEO Seth M. Shaw commented, "The Board of Directors believes that the timing is now correct to seriously evaluate potential opportunities with the goal of consummating potential attractive acquisition and licensing transactions during calendar year 2018. The Company wishes to thank its many shareholders for their loyalty exhibited over the past two and half years and management will do its very best to reward its shareholders with a successful long term future."
http://www.marketwired.com/press-release/tauriga-sciences-inc-focused-on-consummating-significant-transactions-build-long-term-pinksheets-taug-2240832.htm
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM